Disseminated intravascular coagulation A condition that causes abnormal blood clotting throughout the bodys small blood vessels
Risk Factors and Vulnerable Populations Certain patients face higher risks of developing foot complications during GLP-1 treatment: Diabetic Patients: Those with type 2 diabetes already have an increased risk of diabetic foot complications, including neuropathy and foot ulcers
The decision for the blend over a single substance is ultimately a question of the research question: synergy and pulse logic on the one hand, defined single-substance kinetics on the other
PMID: 23048011 Davis SR, Baber R, Panay N, et al
As of the time of writing, retatrutide has not been granted a marketing authorisation by the MHRA or EMA, and therefore no formal UK product labelling or Summary of Product Characteristics (SmPC) exists
So what I just discussed are the two major players are the two most often